Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mendell

Showing results (121-130 of 889) with videos related to

Pageof 89
Sort By:
Muscle & Nerve|September 1, 1995
Amyloidosis causing a progressive myopathyN Nadkarni, M Freimer, J R Mendell
Brain Research|August 29, 1994
CNTF potentiates peripheral nerve regenerationZ Sahenk, J Seharaseyon, J R Mendell
Cell Reports|July 16, 2020
Ribosome Recycling by ABCE1 Links Lysosomal Function and Iron Homeostasis to 3' UTR-Directed Regulation and Nonsense-Mediated DecayXiaoqiang Zhu, He Zhang, Joshua T Mendell
Pediatric Neurology|August 3, 2019
From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1Samiah A Al-Zaidy, Jerry R Mendell
Journal of Cardiovascular Pharmacology|October 16, 2012
Pharmacokinetics of the direct factor Xa inhibitor edoxaban and digoxin administered alone and in combinationJeanne Mendell, Robert J Noveck, Minggao Shi
Journal of Neuropathology and Experimental Neurology|June 18, 1998
Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosisS Erdem, J R Mendell, Z Sahenk
Genetic Epidemiology|January 1, 1995
Integration of linkage analyses and disease association studiesB B Nemesure, Q He, N Mendell
Cell Research|March 2, 2016
Duchenne muscular dystrophy: CRISPR/Cas9 treatmentJerry R Mendell, Louise R Rodino-Klapac
Neuroscience Letters|January 22, 2022
Validation of terminal Schwann cell gene marker expression by fluorescent in situ hybridization using RNAscopeBonnie L Seaberg, Sohum Purao, Mendell Rimer
British Journal of Clinical Pharmacology|August 29, 2012
A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarinJeanne Mendell, Robert J Noveck, Minggao Shi
Pageof 89

Showing results (121-130 of 889) with videos related to

Sort By:
Pageof 89
Muscle & Nerve|September 1, 1995
Amyloidosis causing a progressive myopathyN Nadkarni, M Freimer, J R Mendell
Brain Research|August 29, 1994
CNTF potentiates peripheral nerve regenerationZ Sahenk, J Seharaseyon, J R Mendell
Cell Reports|July 16, 2020
Ribosome Recycling by ABCE1 Links Lysosomal Function and Iron Homeostasis to 3' UTR-Directed Regulation and Nonsense-Mediated DecayXiaoqiang Zhu, He Zhang, Joshua T Mendell
Pediatric Neurology|August 3, 2019
From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1Samiah A Al-Zaidy, Jerry R Mendell
Journal of Cardiovascular Pharmacology|October 16, 2012
Pharmacokinetics of the direct factor Xa inhibitor edoxaban and digoxin administered alone and in combinationJeanne Mendell, Robert J Noveck, Minggao Shi
Journal of Neuropathology and Experimental Neurology|June 18, 1998
Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosisS Erdem, J R Mendell, Z Sahenk
Genetic Epidemiology|January 1, 1995
Integration of linkage analyses and disease association studiesB B Nemesure, Q He, N Mendell
Cell Research|March 2, 2016
Duchenne muscular dystrophy: CRISPR/Cas9 treatmentJerry R Mendell, Louise R Rodino-Klapac
Neuroscience Letters|January 22, 2022
Validation of terminal Schwann cell gene marker expression by fluorescent in situ hybridization using RNAscopeBonnie L Seaberg, Sohum Purao, Mendell Rimer
British Journal of Clinical Pharmacology|August 29, 2012
A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarinJeanne Mendell, Robert J Noveck, Minggao Shi
Pageof 89